clinical trial · NCT03011333
Phase 2B Upper Extremity Nerve Block Study
Postoperative PainHTX-011Bupivacaine HCl without epinephrineSaline Placebo
brief summary
This is a Phase 2B, randomized, assessor-blind, active- and saline placebo-controlled, multicenter study in subjects undergoing augmentation mammoplasty to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of HTX-011 when administered via ultrasound-guided lateral and medial pectoral nerve block before surgery.
started
Jan 14, 2017
primary completion
Feb 1, 2018
completion
Mar 19, 2018
last updated
Mar 2, 2026
official title
A Phase 2B, Randomized, Controlled Study of HTX-011 Administered Via Pectoral Nerve Block in Subjects Undergoing Upper Extremity Surgery for Augmentation Mammoplasty
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol